We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ICHNO 2026
Programme
Imaging, radiomics and artificial...
19 March 2026 - 21 March 2026
Seville, Spain
ICHNO 2026
Session
Imaging, radiomics and artificial intelligence
Session Type:
Poster
Journey:
Add to
My Programme
Prognostic impact of Node-to-Tumor SUVmax ratio in locally advanced nasopharyngeal carcinoma: A single-center experience
SUMERYA DURU BIRGI
,
Turkey
Presentation Number:
-110
Deformable dosimetric analysis of clinical decision on adaptive Head and Neck radiotherapy - a HUman VErsus Machine comparison - HUVEM
Kevin Chiu
,
United Kingdom
Presentation Number:
-202
The Actual Performance of ML/AI Models in Predicting Radiation-Induced Toxicity in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Gibson Ugwu
,
The Netherlands
Presentation Number:
-235
LORIS-like Multimodal Predictive Framework for PFS and response rates to Neoadjuvant therapies: Integrating Imaging, ctDNA in Head and Neck Cancer
Suresh Attili
,
India
Presentation Number:
-293
HERD: Towards integration of advanced MRI and multi-omic biomarkers for early relapse prediction in high-risk head and neck cancer-a prospective study
Sanjena Mithra
,
United Kingdom
Presentation Number:
-298
Potential Utility of Deep Learning Segmentation of Organs at Risk in Oropharyngeal Cancer to Mitigate Risk of Hospitalization During Chemoradiotherapy
Jimmy Caudell
,
USA
Presentation Number:
-399
Real-Time Localization and Classification of Laryngeal (pre)malignancy during Endoscopy using Artificial Intelligence: A Prospective Dual-Center Study
Celine Wilmes
,
The Netherlands
Presentation Number:
-430
[18F]AlF-PSMA-11 PET/CT in stage III–IV head and neck squamous cell carcinoma: interim results of the PANTHEON-18 trial
Michael D. M. Henrotte
,
Belgium
Presentation Number:
-490
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.